The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CABA FINANCIAL STATEMENTS

Cabaletta Bio Inc — balance sheet, income statement and cash flow trends

CABACabaletta Bio Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit616 K $ · Infinity%Operating Income-185.5 M $ · -Infinity%Pre-tax Income-181.3 M $ · -Infinity%Net Income to Owners-181.3 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit616 K $—
Operating Income-185.5 M $—
EBITDA-176.9 M $—
Net Income to Owners-181.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets256.7 M
  • Equity210.6 M $82%
  • Current Liabilities39.9 M $16%
  • Long-term Liabilities6.2 M $2%

Key Figures

YoY change
Total Assets256.7 M $+14.4%
Total Liabilities46.1 M $+0.3%
Total Equity210.6 M $+18.0%
Cash & ST Investments225.1 M $+15.6%
Total Debt25.7 M $+3.3%
Net Debt-199.4 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M0-153.9 M $Operating50.7 M $Investing182.8 M $Financing79.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-153.9 M $—
Capital Expenditures283 K $-82.0%
Free Cash Flow-154.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CABA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.